pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,161 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 252 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: phase readout×type: approval×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings252
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT05094128: A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting

Sponsor: AbbVie. Phase: . Conditions: Axial Spondylarthritis (r-axSpA)

full page →ctgov ↗
›SUSPENDEDphase readoutNCT05118867: Improve the Patients' Recovery With Family- Caregivers to End Delirium

Sponsor: Mayo Clinic. Phase: NA. Conditions: Delirium

full page →ctgov ↗
›RECRUITINGphase readoutNCT07490600: Contingency Management Plus Deep Transcranial Magnetic Stimulation for the Treatment of Cocaine Use Disorder

Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Cocaine Use Disorder (CUD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05140200: Study of GSK3511294 in Healthy Chinese Participants

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Asthma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07088107: A Neurofeedback Interface in Poststroke Neuromodulation Using TMS-fNIRS

Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07105800: Dance Intervention to Improve Executive Function and Physical Performance in Older Adults With Cognitive Impairment

Sponsor: Taipei Medical University Shuang Ho Hospital. Phase: NA. Conditions: Older Adults, Cognitive Impairment, Mild

full page →ctgov ↗
›RECRUITINGphase readoutNCT06547736: Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

Sponsor: Fudan University. Phase: PHASE2. Conditions: Pancreatic Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT02812134: Impact of Oral Phosphorus Supplements on the 6-month Change in FGF23 Levels in Anorexic Adolescents Suffering From Undernutrition.

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Malnutrition

full page →ctgov ↗
›COMPLETEDphase readoutNCT02692664: Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft

Sponsor: JOTEC GmbH. Phase: . Conditions: Iliac Aneurysm, AAA

full page →ctgov ↗
›RECRUITINGphase readoutNCT07578909: Retro Walking With and Without Bosu Ball for Balance and Mobility in Hearing Impaired Children

Sponsor: Riphah International University. Phase: NA. Conditions: Hearing Impaired Children

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06155409: Safety and Performance of the SPINEVISION Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease

Sponsor: SPINEVISION SAS. Phase: . Conditions: Intervertebral Disc Degeneration

full page →ctgov ↗
›RECRUITINGphase readoutNCT06203899: Depression and Suicide Prevention in Adolescents Attending Special Schools

Sponsor: Ggz Oost Brabant. Phase: NA. Conditions: Depressive Symptoms

full page →ctgov ↗
›COMPLETEDphase readoutNCT05160532: Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis

Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Knee Osteoarthritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04673032: Radiofrequency (RF) Ablation Prospective Outcomes Study

Sponsor: Boston Scientific Corporation. Phase: . Conditions: Pain, Chronic

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05717998: Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: . Conditions: Lung Non-Small Cell Carcinoma, GastroEsophageal Cancer, Esophagus Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05714163: Effects of Ai Chi on Scapular Muscle Activation in Overhead Athletes With Scapular Dyskinesis

Sponsor: National Taiwan University Hospital. Phase: . Conditions: Scapular Dyskinesis, Athletic Injuries, Muscle Weakness, Overuse Injury

full page →ctgov ↗
›TERMINATEDphase readoutNCT03420963: Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Neoplasm, Recurrent Malignant Female Reproductive System Neoplasm, Recurrent Malignant Male Reproductive System Neoplasm, Recurrent Malignant Mesothelioma, Recurrent Malignant Neoplasm of Multiple Primary Sites, Recurrent Malignant Oral Neoplasm, Recurrent Malignant Pharyngeal Neoplasm, Recurrent Malignant Skin Neoplasm, Recurrent Malignant Soft Tissue Neoplasm, Recurrent Malignant Solid Neoplasm, Recurrent Malignant Thyroid Gland Neoplasm, Recurrent Malignant Urinary System Neoplasm, Refractory Cutaneous Melanoma, Refractory Malignant Bone Neoplasm, Refractory Malignant Endocrine Neoplasm, Refractory Malignant Female Reproductive System Neoplasm, Refractory Malignant Male Reproductive System Neoplasm, Refractory Malignant Mesothelioma, Refractory Malignant Neoplasm of Multiple Primary Sites, Refractory Malignant Oral Neoplasm, Refractory Malignant Pharyngeal Neoplasm, Refractory Malignant Skin Neoplasm, Refractory Malignant Soft Tissue Neoplasm, Refractory Malignant Solid Neoplasm, Refractory Malignant Thyroid Gland Neoplasm, Refractory Malignant Urinary System Neoplasm

full page →ctgov ↗
›WITHHELDphase readoutNCT06853093: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›RECRUITINGphase readoutNCT06638463: My Health Coach App RCT

Sponsor: University of Rochester. Phase: NA. Conditions: Fetal Alcohol Spectrum Disorders

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05220163: Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19

Sponsor: University of Cape Town. Phase: NA. Conditions: Tuberculosis, COVID-19, HIV Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT06712563: Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

Sponsor: AstraZeneca. Phase: . Conditions: Pulmonary Disease, Chronic Obstructive

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05852587: Xylitol Use for Decolonization of C. Difficile in Patients With IBD

Sponsor: Brigham and Women's Hospital. Phase: PHASE1. Conditions: Inflammatory Bowel Diseases, Clostridioides Difficile Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT05534321: Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease

Sponsor: Baptist Health South Florida. Phase: PHASE1. Conditions: Spine Metastases

full page →ctgov ↗
›RECRUITINGphase readoutNCT05902221: Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE3. Conditions: Infections Joint Prosthetic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06335121: Implementation of PrEP Care Among Women in Family Planning Clinics

Sponsor: Rush University Medical Center. Phase: NA. Conditions: PrEP Uptake, HIV, Prevention

full page →ctgov ↗
›RECRUITINGphase readoutNCT02354014: Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

Sponsor: Janssen Research & Development, LLC. Phase: PHASE2. Conditions: Tuberculosis, Multidrug-Resistant

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07377006: Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Prostate Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03705806: Palliative Thoracic ImmunoRT

Sponsor: University Health Network, Toronto. Phase: . Conditions: Lung Cancer, Nonsmall Cell, Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05862584: Impact of Air Pollution on the Course of Inflammatory Rheumatism

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06613984: Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran)

Sponsor: Pfizer. Phase: . Conditions: COVID-19 Vaccination

full page →ctgov ↗
›COMPLETEDphase readoutNCT07167784: Ecological Momentary Assessment and Physical Activity in Patients With Inflammatory Rheumatic Diseases

Sponsor: University Hospital, Grenoble. Phase: . Conditions: Spondyloarthritis (SpA), Rheumatoid Arthritis & Other Inflammatory Polyarthropathies

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05600933: Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Solid Tumors, Hematologic Malignancy, Gastrointestinal Cancer, Liver Cancer, Pancreatic Cancer, Melanoma, Pre-Malignancy, Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT01413152: Residual Risk Assessment Of HIV Transmission

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis. Phase: NA. Conditions: HIV Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT06401733: Intensive Aerobic and Resistance Exercise Program (IAREP)

Sponsor: National University of Singapore. Phase: NA. Conditions: Type 2 Diabetes Mellitus, Cognitive Impairment, Non-insulin-dependent Diabetes Mellitus, Cognitive Dysfunction

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06959433: Lu-177 PSMA Treatment in Cell Renal Carcinoma

Sponsor: Ankara University. Phase: PHASE3. Conditions: Metastatic Renal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06944652: Stretching to Improve Jumping Performance

Sponsor: University of Saskatchewan. Phase: NA. Conditions: Vertical Jump Performance

full page →ctgov ↗
›RECRUITINGphase readoutNCT06384352: Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›COMPLETEDphase readoutNCT07655947: Theory of Planned Behavior-Based Digital Addiction and Screen Time Management Training for Teachers

Sponsor: Aydin Adnan Menderes University. Phase: NA. Conditions: Digital Addiction and Screen Time Management Among Teachers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07295847: A Study of AZD0120 in Autoimmune Diseases

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07603947: Impact of Forward Head Posture on Postural Stability and Gait Kinematics

Sponsor: Cairo University. Phase: . Conditions: Forward Head Posture, Postural Stability, Gait Analysis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07371247: Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy

Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: EARLY_PHASE1. Conditions: Esophageal Cancer, MRD, ctDNA

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01815749: Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

Sponsor: City of Hope Medical Center. Phase: PHASE1. Conditions: Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT03892148: Protocol of Diuretics Use in Congestive Therapy in Heart Failure

Sponsor: University Hospital, Clermont-Ferrand. Phase: PHASE4. Conditions: Heart Failure, Acute Heart Failure, Chronic Heart Failure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07327255: Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety Lead-In for Dosing in Pregnant Women With Severe Pre-eclampsia

Sponsor: Evergreen Therapeutics, Inc.. Phase: PHASE1. Conditions: Pre-eclampsia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03642626: MT2017-45: CAR-T Cell Therapy for Heme Malignancies

Sponsor: Masonic Cancer Center, University of Minnesota. Phase: PHASE2. Conditions: Acute Lymphoblastic Leukemia, Large B-cell Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07506278: Results Of Vivifrail Exercise In Older Type 2 Diabetic Patients With Fraity Syndrome

Sponsor: National Geriatric Hospital. Phase: NA. Conditions: Type 2 Diabetes, Fraity Syndrome, Exercise Intervention

full page →ctgov ↗
›RECRUITINGphase readoutNCT07368478: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies

Sponsor: Biocity Biopharmaceutics Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Malignancies

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06869785: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Relapsing Multiple Sclerosis (RMS)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07540585: MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients

Sponsor: Indiana University. Phase: . Conditions: Anxiety Disorders, Stress Disorders, Post-Traumatic, Pregnancy, High Risk, Depressive Disorder, Major, Pregnancy Complications, ADHD - Attention Deficit Disorder With Hyperactivity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03979885: Financial Incentives for Smoking Treatment II

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Smoking Cessation, Tobacco Use Cessation

full page →ctgov ↗
← prev
page 91 of 104
next →